A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes

Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up

(2020) Hsuan-Ying Chen et al.   DIABETES CARE

Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study

(2020) Chun-Ting Yang et al.   Cardiovascular Diabetology

Taiwan’s National Health Insurance Research Database: past and future

(2019) Cheng-Yang Hsieh et al.   Clinical Epidemiology

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes

(2018) Kasia J. Lipska et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of intensifying triple oral antidiabetic drug therapy by initiating insulin versus enhancing oral antidiabetic drug therapy on clinical outcomes in patients with type 2 diabetes: a nationwide population-based, propensity score-matched cohort study

(2018) Shihchen Kuo et al.   DIABETES OBESITY & METABOLISM

Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database

(2016) Sheng-Feng Sung et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores

(2016) Samy Suissa et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus

(2015) Przemyslaw Rys et al.   ACTA DIABETOLOGICA

Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan

(2015) Ching-Lan Cheng et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Validation of Acute Myocardial Infarction Cases in the National Health Insurance Research Database in Taiwan

(2014) Ching-Lan Cheng et al.   JOURNAL OF EPIDEMIOLOGY

Concordance between Patient Self-Reports and Claims Data on Clinical Diagnoses, Medication Use, and Health System Utilization in Taiwan

(2014) Chi-Shin Wu et al.   PLoS One

Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy

(2013) S. Cammarota et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study

(2013) Jari Haukka et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Observational Study of the Association of First Insulin Type in Uncontrolled Type 2 Diabetes with Macrovascular and Microvascular Disease

(2012) Gillian C. Hall et al.   PLoS One

Validation of the national health insurance research database with ischemic stroke cases in Taiwan

(2010) Ching-Lan Cheng et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

(2009) Peter C. Austin   COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study

(2009) J. Rosenstock et al.   DIABETOLOGIA

Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin

(2009) Juhaeri Juhaeri et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY